{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:07:07Z","timestamp":1789024027421,"version":"build-2803163510"},"reference-count":66,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"DOI":"10.1080\/14737140.2026.2730175","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:25:26Z","timestamp":1788683126000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory and scientific challenges in pediatric oncology"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1149-3835","authenticated-orcid":false,"given":"Stefania","family":"Bellino","sequence":"first","affiliation":[{"name":"National Center for Drug Research and Evaluation","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lucente","sequence":"additional","affiliation":[{"name":"National Center for Drug Research and Evaluation","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"La Salvia","sequence":"additional","affiliation":[{"name":"National Center for Drug Research and Evaluation","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"6","key":"e_1_3_4_3_1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","article-title":"International incidence of childhood cancer, 2001\u201310: a population-based registry study","volume":"18","author":"Steliarova-Foucher E","year":"2017","unstructured":"Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001\u201310: a population-based registry study. Lancet Oncol. 2017;18(6):719\u2013731.","journal-title":"Lancet Oncol"},{"key":"e_1_3_4_4_1","unstructured":"WHO. Childhood cancer. Access. 2026 Aug 22. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer-in-children"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw4892"},{"key":"e_1_3_4_6_1","unstructured":"American association for cancer research (AACR) paediatric cancer progress report 2025. Available from: https:\/\/cancerprogressreport.aacr.org\/wp-content\/uploads\/sites\/2\/2025\/12\/AACR_PCPR_2025.pdf"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics3010053"},{"key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"1663975","DOI":"10.3389\/fonc.2025.1663975","article-title":"Pediatric tomor microenvironment: developmental dynamics and therapy resistance","volume":"15","author":"George NG","year":"2025","unstructured":"George NG, Rishi B, Dhanda H, et al. Pediatric tomor microenvironment: developmental dynamics and therapy resistance. Front Oncol. 2025;15:1663975.","journal-title":"Front Oncol"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1642279"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01237"},{"key":"e_1_3_4_11_1","unstructured":"European Commission. Reform of EU pharmaceutical legislation. cited 2026 Aug 22]. Available from: https:\/\/health.ec.europa.eu\/medicinal-products\/reform-eu-pharmaceutical-legislation_en?utm_source=chatgpt.com"},{"issue":"2","key":"e_1_3_4_12_1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jnci\/djad239","article-title":"Impact of ACCELERATE paediatric strategy forums: a review of the value of multi-stakeholder meetings in oncology drug development","volume":"116","author":"Pearson ADJ","year":"2023","unstructured":"Pearson ADJ, de Rojas T, Karre D, et al. Impact of ACCELERATE paediatric strategy forums: a review of the value of multi-stakeholder meetings in oncology drug development. J Natl Cancer Inst. 2023;116(2):200\u2013207.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-018-0186-y"},{"key":"e_1_3_4_14_1","volume-title":"Paediatric research Equity Act of 2003, public Law 108\u2013155","author":"US Congress","year":"2003","unstructured":"US Congress. Paediatric research Equity Act of 2003, public Law 108\u2013155. Washington, DC: U.S. Government Printing Office; 2003."},{"issue":"4","key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"e2024066920","DOI":"10.1542\/peds.2024-066920","article-title":"The RACE Act and paediatric trials of adult cancer drugs","volume":"154","author":"Liu ITT","year":"2024","unstructured":"Liu ITT, Kesselheim AS. The RACE Act and paediatric trials of adult cancer drugs. Paediatrics. 2024;154(4):e2024066920.","journal-title":"Paediatrics"},{"key":"e_1_3_4_16_1","unstructured":"Regulation (EC) No 1901\/2006 of the European Parliament and of the Council of. 2006 Dec 12."},{"key":"e_1_3_4_17_1","doi-asserted-by":"crossref","first-page":"1009432","DOI":"10.3389\/fmed.2022.1009432","article-title":"Mandatory requirements for paediatric drug development in the EU and the US for novel drugs\u2014A comparative study","volume":"9","author":"Christiansen H","year":"2022","unstructured":"Christiansen H, De Bruin ML, Hallgreen CE. Mandatory requirements for paediatric drug development in the EU and the US for novel drugs\u2014A comparative study. Front Med (Lausanne). 2022;9:1009432.","journal-title":"Front Med (Lausanne)"},{"key":"e_1_3_4_18_1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejca.2016.04.001","article-title":"Implementation of mechanism of action biology-driven early drug development for children with cancer","volume":"62","author":"Pearson AD","year":"2016","unstructured":"Pearson AD, Herold R, Rousseau R, et al. Implementation of mechanism of action biology-driven early drug development for children with cancer. Eur J Cancer. 2016;62:124\u2013131.","journal-title":"Eur J Cancer"},{"key":"e_1_3_4_19_1","unstructured":"Concept paper on the development of a reflection paper on proof-of-concept data to support the development of anti-cancer medicinal products in paediatric patients. EMA\/32831\/2026."},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.636561"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0926"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00684-9"},{"issue":"1","key":"e_1_3_4_23_1","first-page":"19","article-title":"Developmental origins and emerging therapeutic opportunities for childhood cancer","volume":"176","author":"Filbin MG","year":"2019","unstructured":"Filbin MG, Monje M. Developmental origins and emerging therapeutic opportunities for childhood cancer. Cell. 2019;176(1\u20132):19\u201336.","journal-title":"Cell"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature25480"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature25795"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508054"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.247031"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11121843"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002920"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra035092"},{"key":"e_1_3_4_31_1","first-page":"1591","article-title":"Pediatric pharmacokinetics and pharmacodynamics: current knowledge and future perspectives","volume":"11","author":"Mooij MG","year":"2015","unstructured":"Mooij MG, de Koning BA, Huijsman ML, et al. Pediatric pharmacokinetics and pharmacodynamics: current knowledge and future perspectives. Expert Opin Drug Metab Toxicol. 2015;11:1591\u20131603.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"e_1_3_4_32_1","unstructured":"FDA. General clinical pharmacology considerations for pediatric studies for drugs and biological products. 2022 Sep."},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26636"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw3535"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.09.015"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70105-4"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1304"},{"key":"e_1_3_4_38_1","unstructured":"European Medicines Agency. Reflection paper: formulations of choice for the paediatric population. EMEA\/CHMP\/PEG\/194810\/2005. London: EMA; 2006."},{"key":"e_1_3_4_39_1","unstructured":"International Council for Harmonisation. ICH harmonised guideline E11(R1): clinical investigation of medicinal products in the paediatric population. ICH harmonised guideline E11(R1); 2017."},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21273"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2008.07.008"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.6376"},{"issue":"3","key":"e_1_3_4_43_1","first-page":"4","article-title":"Education, and Welfare; National commission for the protection of human subjects of biomedical and behavioral research. The belmont report. Ethical principles and guidelines for the protection of human subjects of research","volume":"81","author":"Department of Health","year":"2014","unstructured":"Department of Health. Education, and Welfare; National commission for the protection of human subjects of biomedical and behavioral research. The belmont report. Ethical principles and guidelines for the protection of human subjects of research. J Am Coll Dent. 2014 Summer;81(3):4\u201313.","journal-title":"J Am Coll Dent"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1162\/152651603322614382"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-005-0025-9"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02838"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1136"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0094"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03044-0"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30105-0"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2022.2032664"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1680"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa060185"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.0693"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00012-8"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01175"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt089"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.1914"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30671-0"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01581-6"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2026.04.016"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104606"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.148"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2023.164"},{"issue":"6","key":"e_1_3_4_66_1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1158\/1078-0432.CCR-12-2551","article-title":"Is the European paediatric medicine regulation working for children and adolescents with cancer?","volume":"19","author":"Vassal G","year":"2013","unstructured":"Vassal G, Geoerger B, Morland B. Is the European paediatric medicine regulation working for children and adolescents with cancer? Clin Cancer Res. 2013;19(6):1315\u20131325.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_4_67_1","unstructured":"International Council for Harmonisation. ICH harmonised guideline E11(R1): clinical investigation of medicinal products in the paediatric population. Addendum to ICH E11. 2017."},{"key":"e_1_3_4_68_1","unstructured":"FDA Guidance document. Patient-focused drug development: incorporating clinical outcome assessments into endpoints for regulatory decision-making. 2023 Apr."}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2026.2730175","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737140.2026.2730175","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2026.2730175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:39:35Z","timestamp":1789022375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2026.2730175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":66,"alternative-id":["10.1080\/14737140.2026.2730175"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2026.2730175","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}